Evidence map›Paper›PMID 29311235›Full record

ArticleInfection and immunity2018

Deletion of the Major Facilitator Superfamily Transporter

Phillip M Balzano, Aimee L Cunningham, Christen Grassel, Eileen M Barry

Open access · hybridAbstract read
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Deletion Mutants ofPathogens (Basel, Switzerland) · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Phillip M BalzanoInstitute for Global Health, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Aimee L CunninghamInstitute for Global Health, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Christen GrasselInstitute for Global Health, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Eileen M BarryInstitute for Global Health, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA ebarry@medicine.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Correlates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia ModelR01AI123129 · NIAID · ALBANY MEDICAL COLLEGE · PI BARRY, EILEEN M., HAZLETT, KARSTEN R.O. · 2016 to 2020
$3.7M
Advancement of a Defined, Protective, Live Attenuated Tularemia VaccineR01AI102966 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2013 to 2015
$2.1M
NIAID NIH HHS R01 AI102966NIAID NIH HHS R01 AI123129NIAID NIH HHS T32 AI095190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Host-Pathogen InteractionsAnimalsBacterial ProteinsFemaleFrancisella tularensisGene DeletionHumansMaleMembrane Transport ProteinsMiceMice, Inbred BALB CMice, Inbred C57BLMultigene FamilySequence DeletionTularemiaVirulenceBacterial ProteinsMembrane Transport Proteinsamino acid transportFPT mutantsFrancisella tularensismajor facilitator superfamilytularemia

Identifiers

PMID29311235
PMCPMC5820938
OpenAlexW2784153161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.